FDA Approves Gilead’s Next-Generation ‘Breakthrough’ Hepatitis C Drug

Drug Industry Daily
A A
The FDA has approved Gilead’s hepatitis C drug sofosbuvir, which received a unanimous recommendation from agency advisors.

To View This Article:

Login

Subscribe To Drug Industry Daily